Skip to content

MiMedx Group MDXG Current ratio

Current ratio at other companies

IAR
Integra LifeSciencesIART
3.4×+2.2×
Artivion logo
ArtivionAORT
3.9×-1.7×
Solventum logo
SolventumSOLV
1.1×-0.1×
Vericel logo
VericelVCEL
5.2×+0.2×
Enovis logo
EnovisENOV
-0.5×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
4.2×-0.3×

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on the most recent quarter.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's current ratio?
MiMedx Group (MDXG) reported current ratio of 5.4× in Q1 2026.
How has MiMedx Group's current ratio changed year-over-year?
MiMedx Group's current ratio increased by 14.9% year-over-year, from 4.7× to 5.4×.
What is the long-term trend for MiMedx Group's current ratio?
Over 5 years (2020 to 2025), MiMedx Group's current ratio has grown at a 9.7% compound annual growth rate (CAGR), from 2.7× to 4.3×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.